Literature DB >> 6684947

Investigation of diurnal changes in the disposition of theophylline.

D R Taylor, D Duffin, C D Kinney, D G McDevitt.   

Abstract

The mechanism of observed temporal variations in plasma theophylline concentrations has been investigated. Eight healthy volunteers were given both oral and intravenous doses of theophylline (5 mg/kg) at 09.00 h and 21.00 h under controlled conditions. Regular plasma concentration measurements were made following each dose in order to determine the diurnal and nocturnal disposition of the drug. Plasma theophylline concentrations at 0.5 h following each oral dose were 6.9 +/- 0.8 micrograms/ml, a.m., and 3.9 +/- 0.6 microgram/ml, p.m. (P less than 0.05). Time to peak concentration was 1.69 +/- 0.28 h, a.m.; 2.13 +/- 0.23 h, p.m. (P less than 0.05). Values for ka were not significantly different, however. Overall bioavailability, volume of distribution and systemic clearances, calculated for the 12 h period after each dose, did not differ significantly between day and night. Diurnal variations in theophylline disposition do not appear to be the result of changes in metabolism or excretion, but may reflect minor differences in absorption.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684947      PMCID: PMC1428022          DOI: 10.1111/j.1365-2125.1983.tb02186.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Measurement of theophylline in plasma by high performance liquid chromatography.

Authors:  J G Kelly; W J Leahey
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  On observing patterns of airflow obstruction in chronic asthma.

Authors:  M Turner-Warwick
Journal:  Br J Dis Chest       Date:  1977-04

3.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

4.  Single-dose slow-release aminophylline at night prevents nocturnal asthma.

Authors:  P J Barnes; A P Greening; L Neville; J Timmers; G W Poole
Journal:  Lancet       Date:  1982-02-06       Impact factor: 79.321

5.  Pharmacokinetics of theophylline in night-workers.

Authors:  S Decourt; F Fodor; B Flouvat; A Pradalier; J Dry
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

6.  Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics.

Authors:  P H Scott; E Tabachnik; S MacLeod; J Correia; C Newth; H Levison
Journal:  J Pediatr       Date:  1981-09       Impact factor: 4.406

7.  Temporal variations in trough serum theophylline concentrations at steady state.

Authors:  L J Lesko; D Brousseau; A T Canada; G Eastwood
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

8.  Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.

Authors:  H W Kelly; S Murphy
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

9.  Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation.

Authors:  S Pedersen; J Moeller-Petersen
Journal:  Allergy       Date:  1982-10       Impact factor: 13.146

  9 in total
  17 in total

1.  Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.

Authors:  H Chrystyn; J W Ellis; B A Mulley; M D Peake
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

2.  The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.

Authors:  H Lamont; R Pauwels; M Van der Straeten
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

3.  Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.

Authors:  T Uematsu; F Follath; S Vozeh
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Circadian variation in theophylline absorption during chronic dosing with a slow release theophylline preparation and the effect of clock time of dosing.

Authors:  S H Jackson; A Johnston; R Woollard; S M Abrams; P Turner
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

5.  Food and a sustained release theophylline tablet on chronic dosing: bioavailability, peak-trough and trough-trough differences.

Authors:  M Lagas; J H Jonkman
Journal:  Pharm Weekbl Sci       Date:  1985-02-22

6.  Chronopharmacokinetic study with prolonged infusion of midazolam.

Authors:  U Klotz; I W Reimann
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

7.  Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

Review 8.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

9.  Theophylline pharmacokinetics following single and repeated administration of slow-release capsules.

Authors:  J Torrent; I Izquierdo; M J Barbanoj; R Obach; M Nomen; F Jane
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

Review 10.  Molecular clocks in pharmacology.

Authors:  Erik S Musiek; Garret A Fitzgerald
Journal:  Handb Exp Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.